Anticancer award

Guillaume Lessene receives this year's Biota Award for Medicinal Chemistry from the Royal Australian Chemical Institute for his work on small molecules that target a protein involved in tumour development, metastasis, and cancer-drug resistance. Lessene, who is based at the Walter and Eliza Hall Institute in Melbourne, has together with eight co-inventors made a patent application for the compounds, which can trigger apoptosis, programmed cell death, in cancer cells. "It is expected that drugs targeting [these] Bcl-2-like proteins will have a major impact in cancer treatment," Lessene explains.